Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Applied Dna Scns (APDN)

Applied Dna Scns (APDN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 50,905
  • Shares Outstanding, K 7,486
  • Annual Sales, $ 1,930 K
  • Annual Income, $ -13,030 K
  • 60-Month Beta 1.00
  • Price/Sales 26.08
  • Price/Cash Flow N/A
  • Price/Book 2.66
Trade APDN with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.23
  • Number of Estimates 2
  • High Estimate -0.22
  • Low Estimate -0.25
  • Prior Year -0.72
  • Growth Rate Est. (year over year) +68.06%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.65 +17.70%
on 05/25/21
6.80 -2.21%
on 06/21/21
+0.64 (+10.65%)
since 05/21/21
3-Month
5.60 +18.75%
on 05/11/21
9.96 -33.23%
on 04/07/21
-1.98 (-22.94%)
since 03/22/21
52-Week
4.95 +34.34%
on 12/21/20
14.84 -55.19%
on 07/17/20
-1.27 (-16.04%)
since 06/22/20

Most Recent Stories

More News
Applied DNA Sciences and A&E Introduce Anti-Counterfeiting Technology for Sustainable Sewing Threads

Applied DNA Sciences, Inc. (NASDAQ: APDN), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, and American & Efird, (A&E), the world's foremost thread manufacturer, today announced A&E's...

APDN : 6.63 (-2.43%)
Applied DNA Reports Veterinary COVID-19 Vaccine Candidate Induces Neutralizing Antibodies in 100% of Trial Cohort Against B.1.1.7, P1, and B.1.526 Variants and Sets August 2021 Mink Challenge Trial Launch

Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, and its program development partner, Evvivax, S.R.L. ("Evvivax"),...

APDN : 6.63 (-2.43%)
Applied DNA Adds First Summer Camp for safeCircle Pooled COVID-19 Surveillance Testing

Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced that its wholly-owned subsidiary, Applied...

APDN : 6.63 (-2.43%)
Thinking about buying stock in Applied DNA Sciences, Sundial Growers, New Oriental Education, BlackBerry, or Evofem Biosciences?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for APDN, SNDL, EDU, BB, and EVFM.

EVFM : 1.1400 (-2.56%)
SNDL : 0.8987 (-1.24%)
APDN : 6.63 (-2.43%)
BB : 13.25 (+3.52%)
EDU : 7.81 (-3.58%)
Applied DNA Completes Technical Validation of PCR-based SARS-CoV-2 Mutation-Detection Panel, Highlights Ability to Rapidly Identify Mutations and Probable Variants

--- As the Prelude to Whole Viral Genome Sequencing, Mutation Panel Empowers Pursuit of Specific Variant Lineages and Can Minimize Sequencing of Wild Type Virus -

APDN : 6.63 (-2.43%)
Applied DNA Provides Clarification on Newly Authorized Asymptomatic Serial Screening Indication for Linea(TM) COVID-19 Assay Kit and Press Release Published 12 May 2021

Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA or the "Company"), today clarifies the scope of its newly authorized asymptomatic serial screening indication for its Linea COVID-19 Assay Kit (the...

APDN : 6.63 (-2.43%)
Applied DNA Sciences (APDN) Reports Q2 Loss, Tops Revenue Estimates

Applied DNA Sciences (APDN) delivered earnings and revenue surprises of -83.33% and 1.99%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

APDN : 6.63 (-2.43%)
Applied DNA Sciences: Fiscal Q2 Earnings Snapshot

STONY BROOK, N.Y. (AP) _ Applied DNA Sciences Inc. (APDN) on Thursday reported a loss of $1.5 million in its fiscal second quarter.

APDN : 6.63 (-2.43%)
Applied DNA Second Fiscal Quarter 2021 Financial Results Feature 384% Year-Over-Year Growth in Revenues

Applied DNA Sciences, Inc. (NASDAQ: APDN) (the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced consolidated financial results for the three and six months...

APDN : 6.63 (-2.43%)
Applied DNA Sciences, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 13, 2021 / Applied DNA Sciences, Inc. (NASDAQ:APDN) will be discussing their earnings results in their 2021 Second Quarter Earnings call to be held on May 13, 2021 at 4:30...

APDN : 6.63 (-2.43%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Applied DNA Sciences, Inc. provides proprietary DNA-embedded biotechnology security solutions, using non-human DNA, that verify authenticity and protect corporate and government agencies from counterfeiting, fraud, piracy, product diversion, identity theft and unauthorized intrusion. They develop, market,...

See More

Key Turning Points

3rd Resistance Point 7.19
2nd Resistance Point 6.99
1st Resistance Point 6.90
Last Price 6.63
1st Support Level 6.61
2nd Support Level 6.41
3rd Support Level 6.32

See More

52-Week High 14.84
Fibonacci 61.8% 11.06
Fibonacci 50% 9.90
Fibonacci 38.2% 8.73
Last Price 6.63
52-Week Low 4.95

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar